BM reduced the expression of IL-4, IL-13 and p-STAT6 in TNF-α/IFN-γ-induced HaCaT inflammatory cells and in the MC903-induced mouse AD model, thereby effectively improving the expression of the barrier protein FLG/IVL and promoting the recovery of damaged skin. The gene discussed is FLG; the disease is Alzheimer disease.